Subtopic Deep Dive
CRT-D vs CRT-P Device Selection
Research Guide
What is CRT-D vs CRT-P Device Selection?
CRT-D vs CRT-P device selection compares cardiac resynchronization therapy with defibrillator (CRT-D) versus pacemaker-only (CRT-P) devices in heart failure patients to balance arrhythmia prevention against infection risk and cost.
ESC guidelines recommend CRT-D for patients with expected survival >1 year and low defibrillator complication risk, while CRT-P suits higher-risk patients (Brignole et al., 2013; 2797 citations; Glikson et al., 2021; 1700 citations). The DANISH trial showed no mortality benefit of prophylactic ICD in nonischemic heart failure, influencing CRT-P preference (Køber et al., 2016; 1678 citations). Over 10 key ESC guidelines and trials guide selection criteria.
Why It Matters
Optimal CRT-D vs CRT-P selection reduces mortality in heart failure while minimizing complications like infections, which occur in 1-2% of implants annually. Køber et al. (2016) DANISH trial data shows no overall survival gain from defibrillators in nonischemic cardiomyopathy, enabling cost savings of $20,000+ per CRT-P device. Brignole et al. (2013) guidelines inform 100,000+ annual implants worldwide, optimizing resource allocation in resource-limited settings.
Key Research Challenges
Risk Stratification Accuracy
Predicting ventricular arrhythmia risk remains imprecise, leading to over- or under-use of CRT-D. Køber et al. (2016) found no benefit in nonischemic patients despite LVEF <35%. Glikson et al. (2021) highlight need for better biomarkers beyond NYHA class.
Infection and Complication Rates
CRT-D higher lead count increases infection risk versus CRT-P. Ponikowski et al. (2016) note procedural risks outweigh benefits in frail patients. Long-term data gaps persist on device upgrades.
Cost-Effectiveness Modeling
Balancing upfront CRT-D costs against potential SCD prevention lacks robust models. Brignole et al. (2013) recommend life expectancy thresholds, but real-world adherence varies. DANISH trial (Køber et al., 2016) questions value in low-risk cohorts.
Essential Papers
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski, Adriaan A. Voors, Stefan D. Anker et al. · 2016 · European Heart Journal · 11.2K citations
No abstract available.
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Perry Elliott, Aris Anastasakis, Michael A. Borger et al. · 2014 · European Heart Journal · 4.2K citations
NOT AVAILABLE
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
Michele Brignole, Angelo Auricchio, Gonzalo Barón‐Esquivias et al. · 2013 · European Heart Journal · 2.8K citations
Eur Heart J. 2013 Aug;34(29):2281-329. doi: 10.1093/eurheartj/eht150. Epub 2013 Jun 24. \n2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac ...
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
Karl Swedberg, John G.F. Cleland, Henry Dargie et al. · 2005 · European Heart Journal · 2.3K citations
peer reviewed
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
Michael Glikson, Jens Cosedis Nielsen, Mads Brix Kronborg et al. · 2021 · European Heart Journal · 1.7K citations
\n Contains fulltext :\n 239015.pdf (Publisher’s version ) (Closed access)\n
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure
Lars Køber, Jens Jakob Thune, Jens Cosedis Nielsen et al. · 2016 · New England Journal of Medicine · 1.7K citations
In this trial, prophylactic ICD implantation in patients with symptomatic systolic heart failure not caused by coronary artery disease was not associated with a significantly lower long-term rate o...
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Silvia G. Priori, C. Blomström‐Lundqvist, Andrea Mazzanti et al. · 2015 · EP Europace · 1.6K citations
N/A
Reading Guide
Foundational Papers
Start with Brignole et al. (2013 ESC Guidelines; 2797 citations) for core CRT indications, then Køber et al. (2012 Moss MADIT-RIT; 1338 citations) for ICD programming impacting CRT-D efficacy.
Recent Advances
Glikson et al. (2021 ESC; 1700 citations) updates selection criteria post-DANISH; Ponikowski et al. (2016 HF guidelines; 11238 citations) integrates comorbidity risks.
Core Methods
Guideline Class I/IIa recommendations, Kaplan-Meier survival (DANISH trial), ICD programming thresholds (>200 bpm delay; Moss et al., 2012), QRS morphology/LVEF stratification.
How PapersFlow Helps You Research CRT-D vs CRT-P Device Selection
Discover & Search
Research Agent uses searchPapers('CRT-D vs CRT-P DANISH trial') to retrieve Køber et al. (2016), then citationGraph reveals 500+ citing papers and findSimilarPapers uncovers REVERSE-IT analogs. exaSearch scans 250M+ OpenAlex papers for ESC guideline updates.
Analyze & Verify
Analysis Agent applies readPaperContent on Glikson et al. (2021) to extract Class I/IIa recommendations, verifyResponse with CoVe cross-checks DANISH mortality data against Ponikowski et al. (2016), and runPythonAnalysis computes GRADE scores (high for guidelines, moderate for trials) with statistical verification of HRs.
Synthesize & Write
Synthesis Agent detects gaps like post-DANISH risk models, flags contradictions between 2013/2021 ESC guidelines; Writing Agent uses latexEditText for device selection tables, latexSyncCitations for 20+ refs, latexCompile for polished review, and exportMermaid for arrhythmia risk flowcharts.
Use Cases
"Run survival analysis on DANISH trial CRT-D data vs controls"
Research Agent → searchPapers('DANISH Køber') → Analysis Agent → readPaperContent → runPythonAnalysis (pandas Kaplan-Meier curves, log-rank p-values) → researcher gets matplotlib survival plots and HR confidence intervals.
"Draft ESC guideline comparison table for CRT device selection"
Research Agent → citationGraph(Brignole 2013/2021) → Synthesis → gap detection → Writing Agent → latexEditText(table) → latexSyncCitations → latexCompile → researcher gets PDF with synced refs and GRADE ratings.
"Find code for CRT patient risk stratification models"
Research Agent → searchPapers('CRT-D selection model') → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets Python scripts for LVEF/arrhythmia prediction from 5 repos.
Automated Workflows
Deep Research workflow scans 50+ ESC papers via searchPapers chains into structured report with CRT-D/CRT-P meta-analysis tables. DeepScan's 7-step CoVe verifies DANISH (Køber 2016) HRs against guidelines with GRADE checkpoints. Theorizer generates hypotheses on AI-driven selection from Brignole/Ponikowski contradictions.
Frequently Asked Questions
What defines CRT-D vs CRT-P selection?
CRT-D adds defibrillation for SCD risk; CRT-P for pacing-only in low-risk heart failure (Brignole et al., 2013).
What methods guide device choice?
ESC guidelines use LVEF <35%, NYHA II-IV, QRS >130ms, expected survival >1 year for CRT-D; favor CRT-P if high infection risk (Glikson et al., 2021).
What are key papers?
Brignole et al. (2013; 2797 cites) foundational guidelines; Køber et al. (2016 DANISH; 1678 cites) shows no CRT-D mortality benefit.
What open problems exist?
Personalized risk scores beyond LVEF; post-DANISH validation in ischemic HF; cost models for upgrades (Ponikowski et al., 2016).
Research Cardiac pacing and defibrillation studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching CRT-D vs CRT-P Device Selection with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers